Park Ha Biological Technology Co., Ltd.

BYAH Nasdaq SEC CIK 1986247
Follow Park Ha Biological Technology Co., Ltd. Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · US GAAP
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income5 fiscal years
  • Revenue
  • Net income
−$30M−$20M−$10M$0$10MFY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$2.5M−$24.4M
FY24$2.4M$478.6K
FY23$2.5M$852K
FY22$1.9M$191.3K
FY21--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1000%−500%0%500%FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2594.4%−956.5%−965%
FY2491.8%33.3%20.1%
FY2387.4%48%34.6%
FY2273.5%10.3%10%
FY21---
Free cash flowOperating cash flow minus capital expenditure
−$500K$0$500K$1M$1.5MFY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$3K
FY24$874.9K
FY23$103.9K
FY22$1.4M
FY21-
Net margin vs the sectorMedian of Materials companies filing with the SEC
  • Park Ha Biological Technology Co., Ltd.
  • Materials median
−1000%−750%−500%−250%0%250%FY21FY22FY23FY24FY25
Show the numbers
YearPark Ha Biological Technology Co., Ltd.Materials median
FY25−965%2.3%
FY2420.1%3.4%
FY2334.6%4.4%
FY2210%5.6%
FY21-6.4%